Literature DB >> 10426895

Drug interactions with itraconazole, fluconazole, and terbinafine and their management.

A K Gupta1, H I Katz, N H Shear.   

Abstract

A drug interaction develops when the effect of a drug is increased or decreased or when a new effect is produced by the prior, concurrent, or subsequent administration of the other. Before prescribing a drug, it is important to obtain a thorough drug history of the prescription and nonprescription medications taken by the patient. The nonprescription medications may include items such as nutritional supplements and herbal medications. The risk of side effects is an inevitable consequence of drug use. The frequency of adverse reactions is increased in those patients receiving multiple medications. Drug interactions reported in animal or in vitro studies may not necessarily develop in humans. When drug interactions are observed with a particular agent, it cannot be automatically assumed that all closely related drugs will necessarily produce the same interaction. However, caution is advised until sufficient experience accrues. The prescriber should not overestimate or underestimate the potential for a given drug interaction on the basis of personal experience alone. Drug interactions will not necessarily occur in every patient who is given a particular combination of drugs known to produce an interaction. For a clinically significant drug interaction to be manifest, several other factors may be relevant other than just using the two drugs. In many instances drug interactions can be predicted and therefore avoided if the pharmacodynamic effects, the pharmacokinetic properties, and the mechanisms of action of the 2 drugs in question are known. In the case of contraindicated drugs, it may be possible to use an alternative agent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426895     DOI: 10.1016/s0190-9622(99)70055-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

Review 1.  Onychomycosis in the elderly.

Authors:  A K Gupta
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Current Management of Onychomycosis and Dermatomycoses.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

3.  Tinea capitis in infants: recognition, evaluation, and management suggestions.

Authors:  Brent D Michaels; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-02

4.  Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.

Authors:  Stefanie Hennig; Claire E Wainwright; Scott C Bell; Hugh Miller; Lena E Friberg; Bruce G Charles
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.

Authors:  Yoshiyuki Tatsumi; Mamoru Yokoo; Hisato Senda; Kazuaki Kakehi
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 6.  Pharmacology of itraconazole.

Authors:  K De Beule; J Van Gestel
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Current management of fungal infections.

Authors:  J F Meis; P E Verweij
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  High-content analysis of constitutive androstane receptor (CAR) translocation identifies mosapride citrate as a CAR agonist that represses gluconeogenesis.

Authors:  Bryan Mackowiak; Linhao Li; Caitlin Lynch; Andrew Ziman; Scott Heyward; Menghang Xia; Hongbing Wang
Journal:  Biochem Pharmacol       Date:  2019-07-12       Impact factor: 5.858

9.  [Cutaneous alternariosis. Clinical diagnosis and therapeutic options].

Authors:  P Mayser; W Thoma; M Seibold; K Tintelnot; K Wiedemeyer; G S de Hoog
Journal:  Hautarzt       Date:  2004-12       Impact factor: 0.751

10.  Penicillium marneffei presenting as an immune reconstitution inflammatory syndrome (IRIS) in a patient with advanced HIV.

Authors:  Charlotte Hall; Rachel Hajjawi; Gavin Barlow; Hiten Thaker; Kate Adams; Peter Moss
Journal:  BMJ Case Rep       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.